CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Navigo Proteins with ITM to Continue Targeted Radiopharmaceutical Options Research

Life Sciences Review Life Sciences Review | Monday, October 25, 2021
Tweet

Navigo Proteins deepens its partnership with ITM SE.


FREMONT, CA: “We are delighted to continue working with Navigo Proteins and building upon our productive partnership. Our high-quality radioisotopes coupled with Navigo’s Affilin® ligands have the opportunity to unlock an array of precision oncology therapeutics to help patients living with hard-to-treat tumors by positively impacting current treatment algorithms,” states Steffen Schuster, CEO of ITM. Navigo Proteins, a leading protein engineering company focused on developing optimized scaffold protein-based affinity ligands through its Precision Targeting toolbox, has extended its ongoing collaboration with ITM SE, a leading radiopharmaceutical biotechnology company. The firms will collaborate to create targeted radiopharmaceutical options for cancer treatment by combining Navigos Affilin® ligands with ITM's high-quality medical radioisotopes. The cooperation will now be strengthened further with the addition of another precision oncology targeted radionuclide therapy initiative.


Affilin® ligands enable the versatile construction of radio conjugates with short and extended half-lives for imaging and therapeutic applications. The target-specific, best-in-class Affilin® ligands are an ideal complement to ITM's precision oncology pipeline, which currently includes agents for neuroendocrine tumors, prostate cancer, glioblastoma, osteosarcoma, and bone metastases, as well as folate receptor Î positive tumors such as lung, ovarian, or breast cancer.


Henning Afflerbach, CEO of Navigo Proteins, comments, "We have very promising ongoing projects with ITM, and this continuation and expansion of our partnership validates our Affilin® based approach for creating pure and precise next-generation radiotherapeutics. Navigos Precision Targeting toolbox allows the design and development of highly homogenous, Affilin® radio conjugates with fine tunable half-lives. The long-standing, successful relationship with ITM as a leading partner in precision oncology is a further step on our way to deliver best-in-class targeted radionuclide therapies."


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/navigo-proteins-with-itm-to-continue-targeted-radiopharmaceutical-options-research-nwid-602.html